Literature DB >> 14734106

Activation of dendritic cells: translating innate into adaptive immunity.

Caetano Reis e Sousa1.   

Abstract

Innate recognition of infection in vertebrates can lead to the induction of adaptive immune responses through activation of dendritic cells (DCs). DCs are activated directly by conserved pathogen molecules and indirectly by inflammatory mediators produced by other cell types that recognise such molecules. In addition, it is likely that DCs are activated by poorly characterised cellular stress molecules and by disturbances in the internal milieu. The multiplicity of innate pathways for DC activation may have evolved to ensure that any signs of infection are detected early, before overwhelming pathogen replication. Understanding which of these signs are both necessary and sufficient to convert DCs into the immunostimulatory antigen-presenting cells that prime appropriate effector T cells may hold the key to improved strategies for vaccination and immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734106     DOI: 10.1016/j.coi.2003.11.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  108 in total

1.  Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation.

Authors:  I Tamayo; J M Irache; C Mansilla; J Ochoa-Repáraz; J J Lasarte; C Gamazo
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

2.  Isolation and partial purification of macrophage- and dendritic cell-activating components from Mycoplasma arthritidis: association with organism virulence and involvement with Toll-like receptor 2.

Authors:  Barry C Cole; Hong-Hua Mu; Nathan D Pennock; Akira Hasebe; Fok V Chan; Leigh R Washburn; Morgan R Peltier
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Bone marrow plasmacytoid dendritic cells can differentiate into myeloid dendritic cells upon virus infection.

Authors:  Elina I Zuniga; Dorian B McGavern; Jose L Pruneda-Paz; Chao Teng; Michael B A Oldstone
Journal:  Nat Immunol       Date:  2004-11-07       Impact factor: 25.606

Review 4.  Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal.

Authors:  Jonathan D Powell; Maureen R Horton
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Complementary function of gamma delta T-lymphocytes and dendritic cells in the response to isopentenyl-pyrophosphate and lipopolysaccharide antigens.

Authors:  Angelo Martino; Rita Casetti; Alessandra D'Alessandri; Alessandra Sacchi; Fabrizio Poccia
Journal:  J Clin Immunol       Date:  2005-05       Impact factor: 8.317

6.  Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells.

Authors:  Giorgio Napolitani; Andrea Rinaldi; Francesco Bertoni; Federica Sallusto; Antonio Lanzavecchia
Journal:  Nat Immunol       Date:  2005-07-03       Impact factor: 25.606

7.  Flt3 ligand generates morphologically distinct semimature dendritic cells in ovalbumin-sensitized mice.

Authors:  Arpita S Bharadwaj; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2006-12-19       Impact factor: 3.362

8.  Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.

Authors:  Zoe Waibler; Martina Anzaghe; Theresa Frenz; Astrid Schwantes; Christopher Pöhlmann; Holger Ludwig; Marcos Palomo-Otero; Antonio Alcamí; Gerd Sutter; Ulrich Kalinke
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

9.  Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells.

Authors:  Flávio V Loures; Adriana Pina; Maíra Felonato; Eliseu F Araújo; Katia R M Leite; Vera L G Calich
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

10.  Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1.

Authors:  Salenna R Elliott; Timothy P Spurck; Joelle M Dodin; Alexander G Maier; Till S Voss; Francisca Yosaatmadja; Paul D Payne; Geoffrey I McFadden; Alan F Cowman; Stephen J Rogerson; Louis Schofield; Graham V Brown
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.